MODIFIZIERTE RNAI-MITTEL

Patent europeic · EP3366775 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3366775
Numer da la dumonda
EP17209680
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-11-2012
Publitgà
29-08-2018
Concedì
27-04-2022
La protecziun finescha il pli tard
15-11-2032
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
C12N 15/113 (2010.01)
A61K 31/7125 (2006.01)
Prioritad
US 201161561710 P 18.11.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 09-07-2025

    Midada

    Published in Swissreg on 09.07.2025

  3. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  4. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  5. 07-03-2023

    Midada

    Published in Swissreg on 07.03.2023

  6. 06-12-2022

    Midada

    Published in Swissreg on 06.12.2022

  7. 27-04-2022

    Concedì

    Published in Swissreg on 27.04.2022

Partidas

Possessur

Alnylam Pharmaceuticals, Inc.

300 Third Street, Cambridge, MA 02142, US

Inventur

MAIER, Martin

Cambridge, MA 02142, US

CHARISSE, Klaus

Cambridge, MA 02142, US

ZIMMERMANN, Tracy

Cambridge, MA 02142, US

RAJEEV, Kallanthottathil, G.

Cambridge, MA 02142, US

MANOHARAN, Muthiah

Cambridge, MA 02142, US

KUCHIMANCHI, Satyanarayana

Cambridge, MA 02142, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.